Aimee El Hed

Title: Aimee El Hed: Innovator in Immune Response Modulation

Introduction

Aimee El Hed is a notable inventor based in Morrisville, NC (US). She has made significant contributions to the field of immunology through her innovative research and patent work. Her expertise lies in the modulation of TGFβ signaling, which has important implications for treating various diseases.

Latest Patents

Aimee El Hed holds a patent titled "Methods of modulating TGFβ signaling." This invention provides methods for identifying the presence of or quantifying T helper (Th) cells and iTreg cells in a sample by detecting the presence of an ADAM, such as ADAM12. The patent also outlines methods for increasing or decreasing TGF signaling by modulating the biological activity or expression of an ADAM. Furthermore, it offers strategies for inhibiting or stimulating immune responses and treating diseases associated with immune responses, including cancer and autoimmune diseases. Aimee's patent represents a significant advancement in therapeutic approaches for various health conditions.

Career Highlights

Aimee El Hed is affiliated with New York University, where she continues her research and development in immunology. Her work has garnered attention for its potential to influence treatment methodologies in the medical field.

Collaborations

Aimee collaborates with Derya Unutmaz, a fellow researcher who contributes to the advancement of their shared goals in immunology. Their partnership exemplifies the importance of teamwork in scientific research.

Conclusion

Aimee El Hed's innovative work in modulating immune responses through her patent on TGFβ signaling showcases her commitment to advancing medical science. Her contributions are paving the way for new therapeutic strategies in treating complex diseases.